SUITABILITY OF A NETWORK META-ANALYSIS OF TARGETED SYNTHETIC OR BIOLOGIC THERAPY FOR PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE BIOLOGIC DMARDS

被引:0
|
作者
Peterson, S. [1 ]
Alfonso-Cristancho, R. [2 ]
Pacou, M. [3 ]
Belhadi, D. [3 ]
Van Sanden, s [4 ]
Webb, T. [1 ]
Ganguly, R. [5 ]
Kurrasch, R. [5 ]
Rao, R. [6 ]
Hsu, B. [1 ]
Popik, S. [1 ]
Jansen, J. P. [7 ]
机构
[1] Janssen Res & Dev LLC, Spring House, PA USA
[2] GlaxoSmithKline Res & Dev Ltd, Collegeville, PA USA
[3] Amaris, Paris, France
[4] Janssen Hlth Econ & Market Access EMEA Stat & Mod, Beerse, Belgium
[5] GlaxoSmithKline, Collegeville, PA USA
[6] GSK Med Res Ctr, Stevenage, Herts, England
[7] Precis Hlth Econ, Oakland, CA USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PMS6
引用
收藏
页码:A141 / A141
页数:1
相关论文
共 50 条
  • [1] Discontinuation rate to biologic and targeted synthetic DMARDs in rheumatoid arthritis patients: Systematic review and meta-analysis
    Convertino, Irma
    Lucenteforte, Ersilia
    Arzenton, Elena
    Giometto, Sabrina
    De Luca, Giulia
    Malanima, Marco
    Ferraro, Sara
    Bonaso, Marco
    Cappello, Emiliano
    Valdiserra, Giulia
    Cazzato, Massimiliano
    Moretti, Ugo
    Mosca, Marta
    Gini, Rosa
    Tuccori, Marco
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 171 - 171
  • [2] Biologic DMARDs and targeted synthetic DMARDs and the risk of all-cause mortality in rheumatoid arthritis: A systematic review and meta-analysis
    Pang, Mengduan
    Sun, Zhe
    Zhang, Hongfeng
    MEDICINE, 2022, 101 (32)
  • [3] The Relative Efficacy of Biologic and Targeted Synthetic DMARDs in Ankylosing Spondylitis: A Network Meta-Analysis
    Diaz, Jesus
    Quiceno, Guillermo
    Ching, Cathy Lee
    Castro, Adela
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 851 - 853
  • [4] COVID-19 outcomes in patients with rheumatoid arthritis with biologic or targeted synthetic DMARDs
    Tsai, Jih-Jin
    Liu, Li-Teh
    Chen, Chun-Hong
    Chen, Liang-Jen
    Wang, Shiow-Ing
    Wei, James Cheng-Chung
    RMD OPEN, 2023, 9 (03):
  • [5] META-ANALYSIS OF SERIOUS INFECTIONS WITH BARICITINIB, TOFACITINIB AND BIOLOGIC DMARDS IN RHEUMATOID ARTHRITIS
    Strand, V.
    Ahadieh, S.
    DeMasi, R.
    Krishnaswami, S.
    Geier, J.
    Menon, S.
    Gomez-Reino, J. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 284 - 284
  • [6] COMPARATIVE EFFICACY OF SYNTHETIC AND BIOLOGIC DMARDS FOR ADULT PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS IN THE RUSSIAN FEDERATION: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Tolkacheva, D.
    Sokolova, V
    Mladov, V
    VALUE IN HEALTH, 2020, 23 : S599 - S599
  • [7] Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis
    Patricia Guyot
    Peter Taylor
    Robin Christensen
    Louisa Pericleous
    Coralie Poncet
    Maximilian Lebmeier
    Pieter Drost
    Gert Bergman
    Arthritis Research & Therapy, 13
  • [8] Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis
    Guyot, Patricia
    Taylor, Peter
    Christensen, Robin
    Pericleous, Louisa
    Poncet, Coralie
    Lebmeier, Maximilian
    Drost, Pieter
    Bergman, Gert
    ARTHRITIS RESEARCH & THERAPY, 2011, 13 (06)
  • [9] COMPARISON OF ABATACEPT AND OTHER BIOLOGIC DMARDS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS PATIENTS: A SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS
    Hochberg, M.
    Janssen, K.
    Broglio, K.
    Walsem, A. V.
    Nadkarni, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 676 - 676
  • [10] Methotrexate Monotherapy and Methotrexate Combination Therapy with Traditional and Biologic Dmards for Rheumatoid Arthritis: A Cochrane Systematic Review and Network Meta-Analysis
    Hazlewood, Glen S.
    Barnabe, Cheryl
    Tomlinson, George A.
    Marshall, Deborah
    Devoe, Daniel
    Bombardier, Claire
    ARTHRITIS & RHEUMATOLOGY, 2015, 67